Dualitas Therapeutics

Dualitas Therapeutics is at the forefront of biotechnology research, pioneering the future of bispecific antibody therapies to combat immune and inflammatory (I&I) diseases and beyond. Through its innovative DualScreen™ discovery engine and expanding collection of unique cell surface proximity engagers, Dualitas Therapeutics is committed to addressing significant unmet patient needs. Their pipeline features promising lead programs like DTX-103 and DTX-102, which have already shown compelling preclinical evidence.

Dualitas Therapeutics is dedicated to advancing the next generation of bispecific therapies. The company focuses on developing solutions for I&I diseases and exploring opportunities beyond, driven by a commitment to innovation and patient well-being. Dualitas Therapeutics continuously seeks to create value through strategic partnerships and the ongoing development of its proprietary technologies.

We invite the manager of Dualitas Therapeutics to enhance your company's presence by creating a customized and exclusive company showcase and product listing on our platform. This is an excellent opportunity to further highlight your groundbreaking work and connect with potential partners and clients.